Article · 8 Apr 2026
ArticlePublished 26 Jun 2024
Investigating the efficacy and mechanisms of action of tuberculosis drugs
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aditya Zade73576* This work encompasses a comprehensive review and investigative study with the objective of advancing Tuberculosis (TB) drug development. The primary aims are structured to provide a nuanced understanding of TB drug efficacy, resistance mechanisms, and the optimization of treatment regimens. Aim involves a critical examination of the effectiveness of existing TB drugs against diverse strains of Mycobacterium tuberculosis ( M. tuberculosis)>, including assessments of treatment success rates, relapse occurrences and the emergence of drug resistance. By scrutinizing the performance and limitations of current treatments, this aim seeks to provide a foundational understanding for subsequent research endeavors. Next, we focus on identifying and evaluating potential new drug candidates for TB treatment. This includes a thorough exploration of the mechanisms of action and potential synergies of novel compounds. We contributed to the development of an innovative drug pipeline capable of overcoming the challenges posed by drug-resistant TB strains. Further, we concentrate on molecular intricacies underlying drug resistance in M. tuberculosis. This includes the characterization of genetic mutations associated with resistance to commonly used antitubercular drugs. By deciphering the genetic situation of drug resistance, this aims to inform targeted strategies for addressing and preventing resistance, fortifying the arsenal against TB. Subsequently, we intended to develop optimized TB treatment regimens by scrutinizing the pharmacokinetics and pharmacodynamics of both existing and novel TB drugs. Investigation into the potential for combination therapies to enhance treatment outcomes is a key component. By optimizing drug regimens, we seek to streamline TB treatment protocols, making them more effective, patient-friendly, and adaptable to the evolving condition of the disease. The outlined objectives provide an overview for achieving the predominant aims of the study. From conducting a thorough literature review to screening potential drug candidates, characterizing drug resistance, and assessing drug interactions, each objective serves as a critical building block in the collective pursuit of advancing TB drug development. This theoretical abstract highlights the significance of a multidimensional approach to TB drug development, emphasizing the synergistic integration of literature review, drug screening, genomic analysis, and pharmacological studies. Through meticulous investigation, the research aspires to contribute theoretical frameworks, methodologies, and insights that can propel the field forward, ultimately leading to more efficacious and consider treatments for TB.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Systematic Reviews in Pharmacy.
Article · 30 Sep 2025
AI?IoT Integration: Balancing Innovation and Compliance in Pharmaceutical Manufacturing
Article · 18 Aug 2025
Investigation of microbiological and organoleptic properties of bee products (bee venom, solid pollen, and royal jelly) through water activity quantification during 8 days of storage
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalSystematic Reviews in Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Aditya Zade”